These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 2496866)
1. One hundred pregnancies after treatment with pulsatile luteinising hormone releasing hormone to induce ovulation. Homburg R; Eshel A; Armar NA; Tucker M; Mason PW; Adams J; Kilborn J; Sutherland IA; Jacobs HS BMJ; 1989 Mar; 298(6676):809-12. PubMed ID: 2496866 [TBL] [Abstract][Full Text] [Related]
2. Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. Homburg R; Armar NA; Eshel A; Adams J; Jacobs HS BMJ; 1988 Oct; 297(6655):1024-6. PubMed ID: 3142595 [TBL] [Abstract][Full Text] [Related]
3. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders. Filicori M; Flamigni C; Meriggiola MC; Ferrari P; Michelacci L; Campaniello E; Valdiserri A; Cognigni G J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487 [TBL] [Abstract][Full Text] [Related]
4. Pulsatile luteinising hormone releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome. Bayram N; van Wely M; Vandekerckhove P; Lilford R; van Der Veen F Cochrane Database Syst Rev; 2000; (2):CD000412. PubMed ID: 10796718 [TBL] [Abstract][Full Text] [Related]
5. The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin-releasing hormone: characterization and management. Filicori M; Flamigni C; Campaniello E; Valdiserri A; Ferrari P; Meriggiola MC; Michelacci L; Pareschi A J Clin Endocrinol Metab; 1989 Oct; 69(4):825-31. PubMed ID: 2506216 [TBL] [Abstract][Full Text] [Related]
6. Induction of ovulation in clomiphene-resistant polycystic ovary syndrome with pulsatile GnRH. Tan SL; Farhi J; Homburg R; Jacobs HS Obstet Gynecol; 1996 Aug; 88(2):221-6. PubMed ID: 8692506 [TBL] [Abstract][Full Text] [Related]
7. Cumulative conception and live birth rates after the treatment of anovulatory infertility: safety and efficacy of ovulation induction in 200 patients. Balen AH; Braat DD; West C; Patel A; Jacobs HS Hum Reprod; 1994 Aug; 9(8):1563-70. PubMed ID: 7989523 [TBL] [Abstract][Full Text] [Related]
8. Induction of ovulation with pulsatile luteinising hormone releasing hormone. Mason P; Adams J; Morris DV; Tucker M; Price J; Voulgaris Z; Van der Spuy ZM; Sutherland I; Chambers GR; White S Br Med J (Clin Res Ed); 1984 Jan; 288(6412):181-5. PubMed ID: 6419847 [TBL] [Abstract][Full Text] [Related]
9. Polycystic ovary syndrome: abnormalities and management with pulsatile gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs. Filicori M; Flamigni C; Campaniello E; Meriggiola MC; Michelacci L; Valdiserri A; Ferrari P Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 2):1737-42. PubMed ID: 2122730 [TBL] [Abstract][Full Text] [Related]
10. Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial. Clifford K; Rai R; Watson H; Franks S; Regan L BMJ; 1996 Jun; 312(7045):1508-11. PubMed ID: 8646142 [TBL] [Abstract][Full Text] [Related]
11. Pulsatile GnRH therapy for the induction of ovulation in hypogonadotropic hypogonadism. Blunt SM; Butt WR Acta Endocrinol Suppl (Copenh); 1988; 288():58-65. PubMed ID: 3138867 [TBL] [Abstract][Full Text] [Related]
12. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH. Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511 [TBL] [Abstract][Full Text] [Related]
13. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Adams J; Franks S; Polson DW; Mason HD; Abdulwahid N; Tucker M; Morris DV; Price J; Jacobs HS Lancet; 1985 Dec 21-28; 2(8469-70):1375-9. PubMed ID: 2867389 [TBL] [Abstract][Full Text] [Related]
14. Pulsatile gonadotrophin-releasing hormone therapy in patients with pituitary tumours treated by surgery and irradiation. Park KH; Park WI; Lee BS; Song CH; Huh KB; Lee HC; Chung SS; Kim GE Clin Endocrinol (Oxf); 1994 Mar; 40(3):407-11. PubMed ID: 8187306 [TBL] [Abstract][Full Text] [Related]
15. Adverse effects of luteinizing hormone on fertility: fact or fantasy. Homburg R Baillieres Clin Obstet Gynaecol; 1998 Dec; 12(4):555-63. PubMed ID: 10627767 [TBL] [Abstract][Full Text] [Related]
16. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial. Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878 [TBL] [Abstract][Full Text] [Related]
17. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome. Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835 [TBL] [Abstract][Full Text] [Related]
18. Ovulation induction with subcutaneous pulsatile gonadotropin-releasing hormone in various ovulatory disorders. Saffan D; Seibel MM Fertil Steril; 1986 Apr; 45(4):475-82. PubMed ID: 3082681 [TBL] [Abstract][Full Text] [Related]